Your browser doesn't support javascript.
loading
Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis: a proof-of-concept study.
Wittoek, Ruth; Carron, Philippe; Lambert, Bieke; Meersseman, Paulien; Verbruggen, Gust; Van den Bosch, Filip; Elewaut, Dirk.
  • Wittoek R; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Carron P; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Lambert B; Department of Radiology and Nuclear Medicine, Ghent University, Ghent, Belgium.
  • Meersseman P; Department of Nuclear Medicine, AZ Maria Middelares, Ghent, Belgium.
  • Verbruggen G; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Van den Bosch F; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Elewaut D; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Ann Rheum Dis ; 77(2): 310-311, 2018 02.
Article en En | MEDLINE | ID: mdl-27932347

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoartritis / Factor de Necrosis Tumoral alfa / Radioinmunodetección / Certolizumab Pegol / Mano Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoartritis / Factor de Necrosis Tumoral alfa / Radioinmunodetección / Certolizumab Pegol / Mano Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article